Anumana vs C8 Health
C8 Health is a care consistency platform for health systems. It keeps a hospital's vetted protocols current, measures clinician performance against local standards, and runs Panda AI, an assistant that answers only from the hospital's own content. The vendor claims more than 150 institutions, naming MetroHealth, Lahey, UTMB Health and Henry Ford Health System. The evidence is perioperative. A 2026 JMIR Human Factors survey of 142 MetroHealth anesthesiology clinicians rated usability 5.73 on average, with authors tied to C8, and a MetroHealth internal study the vendor reports shows ERAS compliance rising from 65% to 88% in five months. C8 states SOC 2 and HIPAA, its homepage names no EHR, and it makes no FDA claim. Anumana's ECG-AI is cleared software that reads a 12-lead ECG for reduced ejection fraction, pulmonary hypertension and cardiac amyloidosis, and a health system's cardiology service line is its buyer.
Decision support · Reviewed November 2, 2026
When to pick each one
Anumana
- FDA 510(k) cleared ECG-AI for low ejection fraction
- Also cleared for pulmonary hypertension and amyloidosis
C8 Health
- Protocol platform with an assistant limited to vetted content
- SOC 2 and HIPAA stated, perioperative evidence base
Score
Each row shows points earned of points available under the published rubric.
Anumana
37of 100
C8 Health
32of 100
| Dimension | Anumana | C8 Health | Difference |
|---|---|---|---|
| FDA clearance | 12 / 12 | 0 / 12 | +12 |
| HIPAA / SOC2 / BAA | 0 / 10 | 10 / 10 | -10 |
| EHR integrations (count) | 0 / 5.6 | 0 / 5.6 | 0 |
| Top-3 EHR coverage (Epic / Oracle / Athena) | 0 / 4.8 | 0 / 4.8 | 0 |
| Bidirectional write-back | 0 / 1.2 | 0 / 1.2 | 0 |
| Peer-reviewed papers | 14.7 / 21 | 8.4 / 21 | +6.3 |
| RCT / meta-analysis / systematic review | 0 / 9 | 0 / 9 | 0 |
| Funding & adoption signal | 3 / 12 | 3 / 12 | 0 |
| Pricing transparency | 1.3 / 2.5 | 1.3 / 2.5 | 0 |
| Years in market | 0 / 6 | 4.2 / 6 | -4.2 |
Scroll horizontally to see every column.
Pricing
Anumana
| Tier | Monthly | Annual | Notes |
|---|---|---|---|
| Enterprise | n/a | n/a | No public price. The pricing page returns 404; the site offers a demo request only. |
C8 Health
| Tier | Monthly | Annual | Notes |
|---|---|---|---|
| Enterprise | n/a | n/a | No public price. |
Evidence
Anumana
FDA decisions
K253801 (opens in new tab)510(k)2026-04-07
ECG-AI Cardiac Amyloidosis (CA) 12-Lead Algorithm (1040)
K252360 (opens in new tab)510(k)2026-03-28
ECG-AI Pulmonary Hypertension (PH) 12-Lead algorithm (1020)
K250652 (opens in new tab)510(k)2025-07-28
ECG-AI Low Ejection Fraction (LEF) 12-Lead algorithm (1010)
K232699 (opens in new tab)510(k)2023-09-28
Low Ejection Fraction AI-ECG Algorithm
Peer-reviewed
3 PubMed records name Anumana.
- A Pragmatic Trial Evaluating the Impact of the Anumana Clinical Decision Support Tool for Guideline-Directed Management of Heart Failure (ACT-HF): Clinical trial design and methods. (opens in new tab)
- Comment on "A pragmatic trial evaluating the impact of the anumana clinical decision support tool for guideline-directed management of heart failure (ACT-HF): Clinical trial design and methods". (opens in new tab)
- Identification and risk stratification of coronary disease by artificial intelligence-enabled ECG. (opens in new tab)
C8 Health
FDA decisions
No FDA decision cited in our research as of November 2, 2026.
Peer-reviewed
1 PubMed record names C8 Health.
Compliance and integrations
Documented from each vendor’s own pages.
| Spec | Anumana | C8 Health |
|---|---|---|
| Free tier | ||
| HIPAA | ||
| SOC 2 Type II | ||
| EHR integrations | Not specified | Not specified |
| Founded | n/a | 2019 |
| HQ | US | US |
Scroll horizontally to see both columns.
Common questions
Open the full decision support comparison
Differential diagnosis, treatment guidance, drug interactions, evidence-grounded Q&A. The CDS landscape ranges from the UpToDate gold standard to physician-only OpenEvidence. We compared what clinicians actually use.